Page last updated: 2024-09-05

l 778,123 and Neutropenia

l 778,123 has been researched along with Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Britten, CD; Deutsch, P; Lee, Y; Lobell, RB; Mazina, KE; McCreery, H; Patnaik, A; Pezzuli, S; Rowinsky, EK; Soignet, S; Spriggs, D; Yao, SL	1

Trials

1 trial(s) available for l 778,123 and Neutropenia

Article	Year
A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12 Topics: Adult; Alkyl and Aryl Transferases; Area Under Curve; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Imidazoles; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Thrombocytopenia	2001

Article

Year

A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:12

Topics: Adult; Alkyl and Aryl Transferases; Area Under Curve; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Imidazoles; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Thrombocytopenia

2001